Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
نویسندگان
چکیده
منابع مشابه
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
BACKGROUND AND PURPOSE Treatment with statins reduces the rate of cardiovascular events in high-risk patients, but residual risk persists. At least part of that risk may be attributable to atherogenic dyslipidemia characterized by low high-density lipoprotein cholesterol (≤40 mg/dL) and high triglycerides (triglycerides≥150 mg/dL). METHODS We studied subjects with stroke or transient ischemic...
متن کاملAtherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
Childhood obesity when associated with serum lipoprotein changes triggers atherosclerosis. Evidences suggest that the atherosclerotic process begins in childhood and that the extent of early atherosclerosis of the aorta and coronary arteries can be associated with lipoprotein levels and obesity. Furthermore, many studies in childhood demonstrate an important relationship between parameters of i...
متن کاملPrevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
INTRODUCTION Atherogenic dyslipidemia is an important risk factor for cardiovascular disease. We aim to determine atherogenic dyslipidemia prevalence in primary care patients at moderate-very high cardiovascular risk and its associated cardiovascular risk perception in Spain. METHODS This cross-sectional study included 1137 primary care patients. Patients had previous cardiovascular disease, ...
متن کاملAtherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
OBJECTIVE Timely recognition and optimal management of atherogenic dyslipidemia (AD) and residual vascular risk (RVR) in family medicine. BACKGROUND The global increase of the incidence of obesity is accompanied by an increase in the incidence of many metabolic and lipoprotein disorders, in particular AD, as an typical feature of obesity, metabolic syndrome, insulin resistance and diabetes ty...
متن کاملPrevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).
BACKGROUND Despite clear guideline recommendations, there is a growing body of evidence that there is suboptimal use of lipid-lowering treatment in Canadians. OBJECTIVE To assess the prevalence and types of persistent lipid abnormalities in Canadian patients receiving statin therapy. METHODS The present cross-sectional study recruited 2436 outpatients 45 years of age or older who were treat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2014
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.113.004229